| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Feb 2025 | 6 Feb 2025 |
| CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Unaudited Standalone and Consolidate Financial Results of the Company for the quarter and nine months ended December 31 2024. UFR for the quarter and nine months ended December 31, 2024 (As Per BSE Announcement Dated on 14.02.2025) | ||
| Board Meeting | 2 Jan 2025 | 31 Dec 2024 |
| Inter alia, to consider, discuss and decide various matters in connection with the Rights Issue, including the specific terms of the Rights Issue, such as the determination of the Rights Issue price and related payment mechanism, rights entitlement ratio, the record date and timing of the Rights Issue Outcome of the meeting of the Securities Issue and Allotment Committee of the Board of Directors of Camlin Fine Sciences Limited (the Company) held on January 2, 2025. (As Per BSE Announcement Dated on 02.01.2025) | ||
| Board Meeting | 22 Nov 2024 | 18 Nov 2024 |
| CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/11/2024 inter alia to consider and approve the revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and Issue of any debt securities of the Company. We wish to inform you that the Board of Directors of the Company at its meeting held today, i.e., Friday, November 22, 2024, inter alia, considered and approved the revision of the quantum of the proposed Rights Issue to an amount not exceeding Rs. 225 crores; and The proposal for fund raising by way of issuance of up to 10,000 (Ten Thousand) senior, secured, redeemable, unlisted, unrated, non-convertible debentures of face value of Rs. 100,000 (Rupees One Lakh only) each (NCDs) aggregating for an amount of Rs. 100,00,00,000 (Rupees One Hundred Crores only) on a private placement basis. (As Per BSE Announcement dated on 22.11.2024) | ||
| Board Meeting | 11 Nov 2024 | 28 Oct 2024 |
| Quarterly Results CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve the Unaudited Standalone and Consolidate Financial Results of the Company for the quarter and half year ended September 30, 2024. (As Per BSE Announcement dated on 28.10.2024) Unaudited Financial Results - 30.09.2024 (As Per BSE Announcement Dated on: 11/11/2024) | ||
| Board Meeting | 10 Sep 2024 | 5 Sep 2024 |
| CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/09/2024 inter alia to consider and approve the proposal for raising of funds by way of rights issue of equity shares under applicable laws or issue of any other securities of the Company Outcome of the Board Meeting - Approval for fund raising proposal For the purposes of giving effect to the rights issue, the detailed terms to the rights issue including but not limited to issue price, rights entitlement ratio, record date, timing and terms of payment will be determined in due course by the Board, or the Securities Issue and Allotment Committee constituted by the Board, in accordance with applicable laws, subject to receipt of necessary approvals, as may be required. Outcome of the Board Meeting - Approval for fund raising proposal (As Per BSE Announcement dated on 10.09.2024) | ||
| Board Meeting | 12 Aug 2024 | 5 Aug 2024 |
| CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the standalone and consolidated un-audited financial results of the Company for the quarter ended June 30 2024. UFR 30.06.2024 (As Per BSE Announcement Dated on: 12/08/2024) | ||
| Board Meeting | 20 May 2024 | 8 May 2024 |
| CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 inter alia to consider and approve Intimation about the Board Meeting to be held on May 20 2024 to consider and approve the standalone and consolidated audited financial results for the quarter / year ended March 31 2024 AFR 31st March, 2024 Appointment of Secretarial Auditor and Cost Auditor for FY 2024 - 2025 (As Per BSE Announcement dated on 20.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
